Preferential siRNA delivery to injured kidneys for combination treatment of acute kidney injury
Authors:
- 23 November 2021
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 341, 300-313
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 DK120533)
This publication has 74 references indexed in Scilit:
- p53 Opens the Mitochondrial Permeability Transition Pore to Trigger NecrosisCell, 2012
- Acute Kidney Injury and Mortality in Hospitalized PatientsAmerican Journal of Nephrology, 2012
- Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membraneProceedings of the National Academy of Sciences, 2012
- Atelocollagen-mediated Systemic Delivery Prevents Immunostimulatory Adverse Effects of siRNA in MammalsMolecular Therapy, 2012
- siRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney InjuryJournal of the American Society of Nephrology, 2009
- Activation and involvement of p53 in cisplatin-induced nephrotoxicityAmerican Journal of Physiology-Renal Physiology, 2007
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- Defining Acute Renal FailureClinical Journal of the American Society of Nephrology, 2006
- Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized PatientsJournal of the American Society of Nephrology, 2005
- Plasma Heparin Levels in Normal ManCirculation, 1961